Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection. - sprookjes - yvandenbroek - TriplyDB

Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.

Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.

http://www.wikidata.org/entity/Q36868340

about

Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity Antitumor Responses of Invariant Natural Killer T Cells Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress Immunological battlefield in gastric cancer and role of immunotherapies Glycosyl-Phosphatidyl-Inositol (GPI)-Anchors and Metalloproteases: Their Roles in the Regulation of Exosome Composition and NKG2D-Mediated Immune Recognition Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.Genetics, genomics, and evolutionary biology of NKG2D ligands.NKG2D Receptor and Its Ligands in Host Defense Immunity, inflammation, and cancer: an eternal fight between good and evil.Immunosurveillance and immunotherapy of tumors by innate immune cells.Expression of the inhibitory Ly49E receptor is not critically involved in the immune response against cutaneous, pulmonary or liver tumours.Expression and prognostic significance of unique ULBPs in pancreatic cancer Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy.T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System.The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma.Xanthine oxidoreductase is required for genotoxic stress-induced NKG2D ligand expression and gemcitabine-mediated antitumor activity CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells Alternative Splice Transcripts for MHC Class I-like MICA Encode Novel NKG2D Ligands with Agonist or Antagonist Functions.A hematopoietic cell-driven mechanism involving SLAMF6 receptor, SAP adaptors and SHP-1 phosphatase regulates NK cell education.Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape.Antigen Loss Variants: Catching Hold of Escaping Foes.VEGFR2-targeted fusion antibody improved NK cell-mediated immunosurveillance against K562 cells.NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors Regulation of NKG2D-Dependent NK Cell Functions: The Yin and the Yang of Receptor Endocytosis.A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA.Antibody targeting soluble NKG2D ligand sMIC refuels and invigorates the endogenous immune system to fight cancer.Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation.Distinct mechanisms of tumor resistance to NK killing: of mice and men.Shed NKG2D ligand boosts NK cell immunity The dual role of NK cells in antitumor reactions triggered by ionizing radiation in combination with hyperthermia The immune system in cancer metastasis: friend or foe?TriKEs and BiKEs join CARs on the cancer immunotherapy highway.Endothelial cells express NKG2D ligands and desensitize anti-tumor NK responses.Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8+ T Cells and Histone Acetyltransferases.Chronic NKG2D Engagement In Vivo Differentially Impacts NK Cell Responsiveness by Activating NK Receptors.An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells.

P2860

Q26751011-FF8F868C-B7D6-40FB-9480-ABB81EB05E4F Q26752518-61C2B60B-CD22-4DA4-89B4-37E87E930F75 Q26772347-9CF47BB6-E5BB-4F5D-B207-10D135A2FBFD Q26773135-60D8F75D-CBBE-4865-906E-ACB4FE346287 Q26778648-419CB3AA-0401-4EFC-A468-E5B1C80DAEC8 Q26781260-F82AABDA-60FF-4BF9-9CA5-869DC5F2758A Q28071836-2693520A-E2A2-46A7-8012-DDEC70BC46C7 Q28076151-FC825C0A-99C6-4B85-BF63-C52B765EC5D7 Q30648415-ED6211CC-AF87-463A-92BC-BAE61CD11247 Q34489980-D0934092-923C-4D39-9537-1410886C64B4 Q35687826-3DB8967A-BC80-4EFB-871F-63082421A3CA Q36106053-A52B2DB8-2EF6-4A50-A5AE-11B2173518C7 Q36471212-8946052E-CFD0-48AA-9452-9D7E8F4F5AFE Q37137278-C0B830FF-5E74-4EE0-B71E-4A66DE7EB84F Q37229770-3E2A25F7-07CB-4152-B681-4342AE57342E Q37281838-5D114D3F-B084-4849-9EA7-FBFE61D64C44 Q37598020-13345D94-0655-41AF-B15F-7A8C7B5DFBBA Q37622429-5C907AE2-7D0B-4C3F-8BAB-C0E71048B431 Q37644845-353658BE-6C54-4A6F-9817-4E39CE2A2311 Q37654516-E43CC597-5EBE-40AE-911A-33DF91624403 Q38762336-9F2F9E65-B97B-4E88-A4DF-CD46764C1ADE Q38794091-182FF164-8932-48BD-A616-A328AF0E48D6 Q38860610-2D6EAC14-8449-42DF-9314-9F6824CA32BB Q38958563-DD97C12E-8A6A-4235-A309-3A5EB411DA54 Q39175440-75856A51-4033-4891-88A0-0E44EEC93788 Q39787455-62C5987B-6244-4334-BB96-723A8A167BC8 Q39798606-35D9656E-5002-41D7-9CAE-C9C87FA8EE7A Q40098295-ADB1C54F-A99C-4A8C-A7D3-B7130162C756 Q40257100-32403C9C-D5A7-4910-AD0A-2A3C28E2A0E0 Q40436097-4F5D847F-45FB-4B96-B983-81E556D62F27 Q41067927-7ED31DBF-5BC1-404F-8439-40DF154F6E3C Q41097352-3423E357-ACA4-442A-AA0F-300D4753EBD5 Q42148086-39B59572-6B51-4E1F-82DD-C7771188985E Q42427640-BB53ACF6-5A28-4411-8EE9-855D067CC7CE Q42656251-88D74B4C-C741-4AAB-9AA7-B42862CB593D Q42801713-5B1A74F0-8542-4EE1-B5E1-8E62A47A3E0B Q46018291-B0C6E3F2-0647-470A-85B9-89A1DB3B0B92 Q46884989-A7AE634E-3A41-483A-B7D1-A5290EFEC466 Q47114951-D4AA0A76-B1CD-4014-B766-41C28BD34D36 Q49884881-71AAD947-93F6-4C35-A172-94442E3260D7

P2860

Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.

http://www.wikidata.org/entity/Q36868340

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Antitumor immunity. A shed NKG ...... ctivation and tumor rejection.

@en

type

label

Antitumor immunity. A shed NKG ...... ctivation and tumor rejection.

@en

prefLabel

Antitumor immunity. A shed NKG ...... ctivation and tumor rejection.

@en

P1433

Q36868340-53A6E44C-1D4A-4150-924D-1D3478927DDC

P1476

Q36868340-1F2B4D91-F4C0-4F9B-9FE5-6BEB21EC70CA

P2093

Q36868340-08953476-ABA4-4E4A-BF5D-F3545EC42706

Q36868340-27553000-1365-4181-87A3-77D9CA775575

Q36868340-463D55C9-31D3-4329-83C8-9557629E5975

Q36868340-A9FEF727-D9E9-432B-8609-82EBD72D5687

Q36868340-CE44A015-5A60-4C39-9F94-012403E3870C

Q36868340-D900F386-6A7A-43C1-BED9-17FC2B6E8491

Q36868340-F1C2B982-E5F7-4D5C-96FB-1EBE4A091B48

P2860

Q36868340-0CBF1C90-F810-4CAD-A493-047DC973C10F

Q36868340-17E501D0-4113-4CC8-A74B-ECF52E428C10

Q36868340-27BB45E4-2D6B-41E6-9A73-047104CD7FA3

Q36868340-27FE941F-959D-4523-947E-6532DFCCD155

Q36868340-2BAEDB1A-9A78-4CBA-8B58-CC870C158D9C

Q36868340-3C0536DD-225C-4900-9F9C-3B6D80F92494

Q36868340-3FFC55CE-6D23-4D7B-96E1-2B316D9892FB

Q36868340-411AAE45-661D-4F75-A5D5-32C0E3A65054

Q36868340-41FEF374-721F-47AC-AF49-2AA6959E906F

Q36868340-43DA9193-51D8-42E8-8541-44B303118589

P304

Q36868340-FE752C66-015B-457C-BF79-4B98476A6D8C

P31

Q36868340-FA0A3039-7A4D-466B-A587-8432C41373A8

P356

Q36868340-18C2043B-FE56-4D1F-82B1-AC00FAB7B26E

P407

Q36868340-8133151E-5F08-4014-90B3-CB3128575CC9

P433

Q36868340-B4102A6C-8E38-47A1-A91B-157B345794B7

P478

Q36868340-6B7174AA-57C7-4A6A-917A-C311CF8CA6B8

P50

Q36868340-6AA59204-9479-4E89-BCE2-DAE592A92FEE

Q36868340-9B677B33-871E-492F-BC6A-1F8967F42A6A

Q36868340-EF966F41-6FE5-41D5-8C77-B9DDE4656B62

P577

Q36868340-681A5135-3670-4C9B-AF5A-826AB0195C8D

P698

Q36868340-FC8FC3B1-0AFA-4019-B6BB-5A979D76DA1F

P932

Q36868340-B66B84F5-F9CF-43D6-8F5A-275B639886E6

P356

SCIENCE.1258867

P1433

P1476

Antitumor immunity. A shed NKG ...... ctivation and tumor rejection.

@en

P2093

Alexandre Iannello

http://www.w3.org/2001/XMLSchema#string

Jianfeng Xu

http://www.w3.org/2001/XMLSchema#string

Li Zhang

http://www.w3.org/2001/XMLSchema#string

Lin Wang

http://www.w3.org/2001/XMLSchema#string

Na Xiong

http://www.w3.org/2001/XMLSchema#string

Stephanie Lau

http://www.w3.org/2001/XMLSchema#string

Weiwen Deng

http://www.w3.org/2001/XMLSchema#string

P2860

Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes

Redistribution and pinocytosis of lymphocyte surface immunoglobulin molecules induced by anti-immunoglobulin antibody

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering

Cellular expression, trafficking, and function of two isoforms of human ULBP5/RAET1G.

Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses.

Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients.

Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.

Roles of the NKG2D immunoreceptor and its ligands.

Regulation of ligands for the NKG2D activating receptor.

Stress-regulated targeting of the NKG2D ligand Mult1 by a membrane-associated RING-CH family E3 ligase.

P304

136-139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.1258867

http://www.w3.org/2001/XMLSchema#string

P407

P433

6230

http://www.w3.org/2001/XMLSchema#string

P478

348

http://www.w3.org/2001/XMLSchema#string

P50

David H. Raulet

Tihana Lenac Rovis

Benjamin G Gowen

P577

2015-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25745066

http://www.w3.org/2001/XMLSchema#string

P932

4856222

http://www.w3.org/2001/XMLSchema#string